S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
New "Mined in America" Lithium Opportunities? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
The Graphite Shortage Story You're Not Being Told (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
New "Mined in America" Lithium Opportunities? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
The Graphite Shortage Story You're Not Being Told (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
New "Mined in America" Lithium Opportunities? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
The Graphite Shortage Story You're Not Being Told (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
New "Mined in America" Lithium Opportunities? (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
New "Mined in America" Lithium Opportunities? (Ad)
Economic boost or big business hand-out? Nevada lawmakers consider A's stadium financing
Workday: Another AI Winner Melting-Up 
The Graphite Shortage Story You're Not Being Told (Ad)
Krystal Clear: Krystal Biotech Clears Resistance in Good Volume
Taiwan Semiconductor Well Positioned for the AI Rush
CVE:ADK

DIAGNOS (ADK) Stock Forecast, Price & News

C$0.36
-0.01 (-1.35%)
(As of 05/29/2023 04:45 PM ET)
Compare
Today's Range
C$0.36
▼
C$0.37
50-Day Range
C$0.27
▼
C$0.45
52-Week Range
C$0.13
▼
C$0.45
Volume
53,743 shs
Average Volume
115,578 shs
Market Capitalization
C$25.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsInsider TradesHeadlines

ADK stock logo

About DIAGNOS (CVE:ADK) Stock

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.

Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Stock News Headlines

May 17, 2023 | finance.yahoo.com
DIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of “IRIS-ai powered by DIAGNOS”
May 15, 2023 | baystreet.ca
TMX, Arrow, CPKC at 52-Week Highs on News
May 30, 2023 | Edge On The Street (Ad)
Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
May 11, 2023 | usatoday.com
Michael J. Fox: Do you have Parkinson's? New test is 'breakthrough' in diagnosing disease.
May 4, 2023 | theglobeandmail.com
Closing Bell: Diagnos Inc up on Wednesday (ADK)
May 2, 2023 | theglobeandmail.com
Closing Bell: Diagnos Inc up on Monday (ADK)
April 28, 2023 | theglobeandmail.com
Closing Bell: Diagnos Inc up on Thursday (ADK)
April 19, 2023 | theglobeandmail.com
Closing Bell: Diagnos Inc up on Tuesday (ADK)
May 30, 2023 | Edge On The Street (Ad)
Is Graphite the New Lithium?
Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.
April 9, 2023 | americanbankingnews.com
FY2023 EPS Estimates for DIAGNOS Inc. Reduced by Echelon Wealth Partners (CVE:ADK)
April 8, 2023 | americanbankingnews.com
Q4 2023 Earnings Estimate for DIAGNOS Inc. (CVE:ADK) Issued By Echelon Wealth Partners
February 28, 2023 | finance.yahoo.com
DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts
December 15, 2022 | finance.yahoo.com
DIAGNOS Provides Additional Information to the Closing of Private Placement
November 6, 2022 | reuters.com
ADK.V - Diagnos Inc | Stock Price & Latest News | Reuters
October 27, 2022 | finance.yahoo.com
DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
August 18, 2022 | finance.yahoo.com
DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems
July 27, 2022 | finance.yahoo.com
DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics
June 7, 2022 | finance.yahoo.com
DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group
May 26, 2022 | stockhouse.com
DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening
May 12, 2022 | yahoo.com
Ex-attorney general Eric Holder on gerrymandering: 'Republicans have to cheat' in elections
February 10, 2022 | finance.yahoo.com
DIAGNOS Successfully Completes ISO / MDSAP Audit
October 28, 2021 | nz.finance.yahoo.com
DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA
August 17, 2021 | ca.finance.yahoo.com
DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
August 16, 2021 | stockhouse.com
DIAGNOS signs Memorandum of Understanding with Essilor International.
July 20, 2021 | finance.yahoo.com
DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE
March 4, 2021 | finance.yahoo.com
DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology
March 3, 2021 | finance.yahoo.com
DIAGNOS Announces Stock Options Grants
See More Headlines
Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Company Calendar

Today
5/30/2023
Next Earnings (Estimated)
7/12/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Health Information Services
Sub-Industry
N/A
Sector
Computer and Technology
Current Symbol
CVE:ADK
CUSIP
N/A
CIK
N/A
Web
www.diagnos.ca
Phone
+1-450-6788882
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-2,480,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-121.31%

Debt

Debt-to-Equity Ratio
245.28
Current Ratio
1.42
Quick Ratio
0.68

Sales & Book Value

Annual Sales
C$577,486.00
Price / Sales
43.91
Cash Flow
C$0.01 per share
Price / Cash Flow
60.00
Book Value
C($0.02) per share
Price / Book
-18.25

Miscellaneous

Outstanding Shares
69,470,000
Free Float
N/A
Market Cap
C$25.36 million
Optionable
Not Optionable
Beta
-0.09

Key Executives

  • Mr. Andre Larente
    CEO, Pres & Exec. Director
  • Mr. Marc-André Massue
    VP of Fin., CFO & Sec.
  • Mr. Guillermo Moreno Robles
    VP of Sales
  • Mr. Martin Beland
    Director of Marketing

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













ADK Stock - Frequently Asked Questions

How have ADK shares performed in 2023?

DIAGNOS's stock was trading at C$0.28 at the beginning of the year. Since then, ADK stock has increased by 30.4% and is now trading at C$0.37.
View the best growth stocks for 2023 here.

When is DIAGNOS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 12th 2023.
View our ADK earnings forecast.

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

What is DIAGNOS's stock symbol?

DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of DIAGNOS?

Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of ADK stock can currently be purchased for approximately C$0.37.

How much money does DIAGNOS make?

DIAGNOS (CVE:ADK) has a market capitalization of C$25.36 million and generates C$577,486.00 in revenue each year. The company earns C$-2,480,000.00 in net income (profit) each year or C($0.04) on an earnings per share basis.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The official website for the company is www.diagnos.ca. The company can be reached via phone at +1-450-6788882.

This page (CVE:ADK) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -